| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
SRA Run Selector
|
Atsushi Suzuki
|
||||||
| GSE90534 |
Transcriptome analysis of the induced hepatocyte-like (iHep) cells
|
28 |
|
Atsushi Suzuki | Aug 06, 2020 | |||
| GSE90536 |
Foxa and Hnf4alpha targets during conversion from mouse embryonic fibroblasts (MEFs) to hepatocyte-like (iHep) cells
|
21 | Atsushi Suzuki | Aug 06, 2020 | ||||
| GSE90538 |
Foxa and Hnf4alpha targets during conversion from mouse embryonic fibroblasts (MEFs) to hepatocyte-like (iHep) cells and hepatocytes (Hep).
|
24 | Atsushi Suzuki | Aug 06, 2020 | ||||
| GSE115423 |
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors
|
9 |
|
Atsushi Suzuki | Oct 02, 2018 | |||
| GSE117332 |
Targets of DNA binding, N-terminal, or C-terminal domain swapped mutant forms fo Foxa proteins in induced hepatocyte-like (iHep) cells.
|
18 | Atsushi Suzuki | Aug 06, 2020 | ||||
| GSE119877 |
Genome-wide maps of the chromatin and transcription state transition during conversion from mouse embryonic fibroblasts (MEFs) to hepatocyte-like cells (iHep)
|
25 |
|
Atsushi Suzuki | Aug 06, 2020 | |||
| GSE119880 |
Targets of Hnf4alpha during conversion from mouse embryonic fibroblasts (MEFs) to hepatocyte-like (iHep) cells.
|
6 | Atsushi Suzuki | Aug 06, 2020 | ||||
| GSE120732 |
Transcriptome analysis of hiHepPCs in various culture conditions, human liver-derived hepatocytes, human liver-derived cholangiocytes, HUVECs, and HPBECs
|
25 |
|
Atsushi Suzuki | Aug 12, 2020 | |||
| GSE143444 |
Targets of transduced Foxa and Hnf4alpha proteins in mouse embryonic fibroblasts (MEFs).
|
16 | Atsushi Suzuki | Aug 06, 2020 | ||||
| GSE168997 |
Transcriptome analysis of human induced liver cancer-forming cells (iLCCs) , HepG2 cells, Huh6 cells, Huh7 cells, and HuCCT1 cells
|
9 |
|
Atsushi Suzuki | Feb 27, 2022 | |||
| GSE184539 |
Transcriptome analysis of liver tumors derived from human induced liver cancer-forming cells (iLCCs)
|
2 |
|
Atsushi Suzuki | Feb 27, 2022 |
